Publications

Publications

Filter Results: (104) Arrow Down

Show Results For

← Page 3 of 104 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • November 2022
  • Case

The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales

By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Pharmaceutical Industry; Health Industry; Retail Industry
Related
  • 15 Jan 2019
  • First Look

New Research and Ideas, January 15, 2019

December 19, 2018 NEJM Catalyst It's Time to Reform the Orphan Drug Act By: Bagley, Nicholas, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern Abstract—No abstract available. Publisher's link:... View Details
Keywords: Dina Gerdeman
  • 19 Dec 2017
  • First Look

New Research and Ideas, December 19, 2017

Abstract—No abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53633 Characterizing the Drug Development Pipeline for Precision Medicines By: Chandra, Amitabh, Craig Garthwaite, and Ariel Dora Stern... View Details
Keywords: Carmen Nobel
  • 21 Aug 2007
  • First Look

First Look: August 21, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807074   PublicationsPerspectives on Risk and Regulation: The FDA at 100 Author:Arthur A. Daemmrich Publication:Chemical Heritage Press, 2007 Abstract Perspectives on Risk and Regulation: The FDA at 100... View Details
Keywords: Martha Lagace
  • 02 Sep 2008
  • First Look

First Look: September 3, 2008

spillover effects. In the domain of private politics, shareholder resolutions filed against a firm, and against others in its industry, increase its propensity to acquiesce to these shareholder requests. Similarly, in the realm of public politics, the threat of state... View Details
Keywords: Sean Silverthorne
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

corporate confessions presents something of a behavioral paradox. Tasked with monitoring the legality of its own operations, why would firms that identify violations turn themselves in to regulators rather than quietly fix the problem?... View Details
Keywords: Martha Lagace
  • 23 Sep 2008
  • First Look

First Look: September 23, 2008

presided over the development of the empirical social sciences to address questions of labor regulation and control within manufacturing industries. Next, we look at the creation of the Carnegie Tech Graduate School of Industrial... View Details
Keywords: Martha Lagace
  • 28 Apr 2009
  • First Look

First Look: April 28, 2009

consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based... View Details
Keywords: Martha Lagace
  • 20 Nov 2007
  • First Look

First Look: November 20, 2007

discipline to nationalized banks. Pharmaceutical Regulation in the United States and Europe Author:Arthur Daemmrich Periodical:Focus on Law Studies 23, no 1 (fall 2007): 8-11 Read the full paper:... View Details
Keywords: Martha Lagace
  • 2023
  • Article

Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance

By: Alexander O. Everhart, Soumya Sen, Ariel D. Stern, Yi Zhu and Pinar Karaca-Mandic
Importance: Most regulated medical devices enter the U.S. market via the 510(k) regulatory submission pathway, wherein manufacturers demonstrate that applicant devices are “substantially equivalent” to 1 or more “predicate” devices (legally marketed medical devices... View Details
Keywords: Recalls; Governing Rules, Regulations, and Reforms; Medical Devices and Supplies Industry
Related
  • 02 Mar 2007
  • What Do You Think?

What Is the Government’s Role in US Health Care?

Newman), the high cost of new technology, artificial restrictions on the supply of drugs (Sergey Mirkiin) and healthcare providers (David Stahl and Michael Robbins), the size and complexity of the problem itself (James Sullivan),... View Details
Keywords: by Jim Heskett; Health
  • 25 Jan 2017
  • HBS Case

How Should Advertisers Respond to Consumer Demand for Whiter Skin?

Hindustan Unilever, the Indian subsidiary of the multinational company Unilever—and sales skyrocketed, leading other companies to quickly follow with their own products. Skincare products are regulated under India’s View Details
Keywords: by Dina Gerdeman; Beauty & Cosmetics
  • 19 Sep 2016
  • Research & Ideas

Why Isn't Business Research More Relevant to Business Practitioners?

disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
Keywords: by Carmen Nobel; Education
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

leaders remain oblivious to an emerging threat or problem—a lack of attention that can plague even the most skilled executives. After European Commission regulators refused to approve General Electric's $42 billion acquisition of... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • 10 Nov 2020
  • Sharpening Your Skills

Research News and Tips: Innovating Across Time Zones

informal deadlines are associated with significantly more adverse effects, including more hospitalizations, life-threatening incidents, and deaths—particularly, drugs most rushed through the approval process." What's going on here? The... View Details
Keywords: by Sean Silverthorne
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 09 Mar 2020
  • Research & Ideas

Warring Algorithms Could Be Driving Up Consumer Prices

The widespread use of pricing algorithms is reshaping the nature of competition in online markets and potentially driving up the prices of retail goods, according to recent research. These automated, price-adjusting software programs may also be catching the eye of... View Details
Keywords: by Kristen Senz; Retail
  • 09 Apr 2012
  • Research & Ideas

Who Sways the USDA on GMO Approvals?

Many corporations have gotten good at pulling the levers of government to tilt the odds in their favor, weakening regulations or securing perks, justified or not, to further their business interests. Economists use the term... View Details
Keywords: by Michael Blanding; Food & Beverage; Biotechnology; Agriculture & Agribusiness
  • 31 Oct 2004
  • Research & Ideas

Bypass Marketing: Are Docs Influenced?

Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
  • 19 Sep 2017
  • First Look

First Look at New Research and Ideas, September 19

Capital Regulation By: Greenwood, Robin, Samuel Gregory Hanson, Jeremy C. Stein, and Adi Sunderam Abstract—We propose three core principles that should inform the design of bank capital regulation. First, wherever possible, multiple... View Details
Keywords: Sean Silverthorne

Are you looking for?

→Search All HBS Web